002864.SZ Stock Analysis
00
Neutral
Based on Eyestock quantitative analysis, 002864.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd. engages in the GAP planting of medicinal materials, drug production, research and development, sales and medical logistics. The company is headquartered in Xi'An, Shaanxi and currently employs 901 full-time employees. The company went IPO on 2017-11-16. The firm's main product is Panlong Qipian, which is for the treatment of orthopedic rheumatism diseases. The firm also provides other Chinese patent drugs for the treatment of hepatobiliary, cardiovascular and cerebrovascular, gynecological and anti-tumor diseases. The firm is also involved in the production and sales of Chinese herbal pieces, as well as the medical commercial distribution business. The firm distributes its products within domestic market.